Q2FY23 Financial Summary and Strategic Highlights
Investing heavily in mid- to long-range pipeline
Continued advancements and disruptions to fuel long-term and share gain/recapture across our Portfolios
Cardiovascular
Medical Surgical
Neuroscience
16
Pulsed
Field
Ablation for
Afib
Symplicity™
procedure for
hypertension
Next-gen
spine
enabling
technologies
Diabetes
Simplera™
CGM
Sensor
Hugo TM RAS System
& Touch Surgery™
Enterprise
advancements
Spinal cord
stim indication
expansion
Signia TM Circular
Stapler
Closed-loop
deep brain
stimulator
Intrasaccular
device for
hemorrhagic stroke
> nutrino
KLUE
Exclusives:
Personalization
& Meal Handling
Multiple undisclosed
development programs
to deliver competitive
CGM/patch pump
technology
IntrepidⓇ Mitral and
Tricuspid Valve
Replacement
Investor Meetings | November 2022
Vital Sync™
patient
monitoring
enhancements
MedtronicView entire presentation